Release Date: 27/04/12 10:32 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 90.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%